Organogenesis Holdings (ORGO) Return on Invested Capital (2017 - 2025)
Organogenesis Holdings (ORGO) posted quarterly Return on Invested Capital of 0.01% for Q2 2025, little changed year-over-year from 0.01% in Q2 2024, and up 9.76% quarter-over-quarter from 0.01% in Q1 2025.
Organogenesis Holdings (ORGO) Return on Invested Capital (2017 - 2025) Analysis & Trends
Organogenesis Holdings' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.01% for Q2 2025.
- In Q2 2025, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM figure through Jun 2025 stood at 0.01% (changed 0.0% YoY), while the FY2023 annual figure was 0.02%, down 6.0% from the prior year.
- Return on Invested Capital for Q2 2025 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.07% in Q4 2021, with the low at 0.01% in Q1 2025.
- The 5-year median for Return on Invested Capital is 0.01% (2023), against an average of 0.02%.
- The sharpest annual moves came in 2021 and 2022: Return on Invested Capital increased 6 bps in 2021, then dropped 6 bps in 2022.
- Organogenesis Holdings' Return on Invested Capital stood at 0.07% in 2021, then plunged by 83 bps to 0.01% in 2022, then sank by 62 bps to 0.0% in 2023, then plunged by 96 bps to 0.0% in 2024, then sank by 5109 bps to 0.01% in 2025.
- Business Quant data shows ORGO's Return on Invested Capital at 0.01% in Q2 2025, 0.01% in Q1 2025, and 0.0% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.01% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 0.03% |
| Jun 30, 2022 | 0.04% |
| Mar 31, 2022 | 0.06% |
| Dec 31, 2021 | 0.07% |
| Sep 30, 2021 | 0.04% |
| Jun 30, 2021 | 0.04% |
| Mar 31, 2021 | 0.02% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | 0.00% |